Prof. Ravin Narain joins as a collaborator with WWiKY.
Dr. Ravin Narain, a Biomedical Engineer at the Faculty of Engineering, University of Alberta, Edmonton, Canada, is collaborating with WWiKY Biosciences Inc. on the preclinical and translational development of innovative thermoresponsive nanotheranostics for the management of hypoxic tumors.
‘No Objection’ Received from Health Canada
WWiKY BioScienes Inc. has received ‘no objection’ from Health Canada to start a Phase I/II theranostic clinical trial in cancer patients. Dr. Michael Sawyer at the Cross Cancer Institute is leading this trial.
Prof. Yvonne Mowery joins Collaboration with WWiKY
Prof. Yvonne Mowery, a well-known radiation oncologist from Department of Radiation Oncology, Hillman Cancer Center, University of Pittsburgh, USA, is collaborating with WWiKY BioSciences on multi-modal therapy evaluation of our pipeline product.
Prof. Tim Smith joins Collaboration with WWiKY
Prof. Tim Smith, Nuclear Futures Institute, Bangor University, United Kingdom, is collaborating with WWiKY BioSciences on therapy evaluation of our pipeline products.